Results 171 to 180 of about 36,083 (204)

Pharmacoeconomic analysis of DPP-4 inhibitors.

Die Pharmazie, 2014
Dipeptidyl peptidase-4 (DPP-4) inhibitors and other incretin-related drugs have attracted attention as antidiabetic agents, but they are expensive. The Japanese government has adopted a policy of reducing healthcare costs, and medical institutions must provide medical care while considering economic efficiency.
H, Teramachi, H, Ohta, T, Tachi, M, Toyoshima, T, Mizui, C, Goto, T, Tsuchiya   +6 more
openaire   +1 more source

[DPP-4 inhibitors in nephropatics].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
The use of glucose-lowering drugs in advanced stage diabetic nephropathic patients should be done very carefully. Some drugs are contraindicated or not recommended. The same insulin needs a dose reduction to avoid dangerous hypoglycemia. For some years the use of inhibitors of the DDP-4 has been approved in T2DM patients with CKD III and IV stage ...
Annamaria, Bruzzese, Maria, Pasquale, Carmela, Aloisi, Giuseppe, Costantino, Michele, Buemi   +4 more
openaire   +1 more source

DPP-4 Inhibitors

2017
T. Biftu, R. SinhaRoy
openaire   +1 more source

Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records

Lancet Diabetes and Endocrinology,the, 2023
Yan Xie, Hong Xian, Ziyad Al-Aly
exaly  

DPP-4 Inhibitors: Monotherapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Lancet Diabetes and Endocrinology,the, 2020
Carolyn S P Lam, Matthew A Cavender, Marit E Jørgensen   +2 more
exaly  

Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids

Pharmaceuticals, 2021
Ahmed A E Mourad, Sameh Saber, Mai A E Mourad   +2 more
exaly  

DPP-4 Inhibitors: Combination Therapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

DPP-4 Inhibitors: An Overview

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly